# Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

> **NCT06182410** · PHASE2 · WITHDRAWN · sponsor: **University of California, San Francisco**

## Conditions studied

- Transplant-Associated Thrombotic Microangiopathy
- Neuroblastoma
- High-risk Neuroblastoma
- Thrombotic Microangiopathies

## Interventions

- **DRUG:** Defibrotide

## Key facts

- **NCT ID:** NCT06182410
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-08-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Industry sponsor decision
- **Last updated:** 2024-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06182410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06182410, "Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06182410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*